Ironshore Pharmaceuticals Completes US$200 Million Financing
Goodmans LLP represented Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc., in the completion of a US$200 million private placement of Senior Secured Notes due 2024. Morgan Stanley & Co. LLC acted as sole placement agent for the transaction.
The proceeds from the financing will provide the necessary resources for Ironshore to complete its evolution from a research and development organization to a fully integrated pharmaceutical company with a world-class Medical Affairs function. The proceeds will also fund pre-commercialization marketing strategies and tactics as well as commercial launch activities for HLD200, a new drug that manages attention deficit hyperactivity disorder (ADHD) which is under review and awaiting approval by the U.S. Food and Drug Administration.
Featured Work
-
Capital Markets
Northwest Healthcare Properties Real Estate Investment Trust announces inaugural unsecured debentures offering
Goodmans LLP advised Northwest Healthcare Properties REIT in connection with a private placement offering of $500 million aggregate principal amount of senior unsecured debentures of the REIT in two… -
Capital Markets
Raymond James Ltd. facilitates $30 million equity financing for Medexus Pharmaceuticals Inc.
Goodmans LLP acted for Raymond James Ltd., as lead underwriter and sole bookrunner, in connection with the $30 million equity financing of Medexus Pharmaceuticals Inc. by way of shelf prospectus… -
Capital Markets
Mandalay Resources Corporation Base Shelf Prospectus
Goodmans LLP advised Mandalay Resources Corporation in connection with its base shelf prospectus dated December… -
Mergers and Acquisitions
NexPoint Hospitality Trust to be acquired by NexPoint Diversified Real Estate Trust
Goodmans LLP is advising NexPoint Hospitality Trust in connection with its announced acquisition by NexPoint Diversified Real Estate Trust… -
Capital Markets
Cormark Securities Inc. leads $51.75 million bought deal offering for Kraken Robotics
Goodmans LLP acted for the underwriters in connection with a bought deal short form prospectus offering of over 32.3 million common shares of Kraken Robotics Inc. for gross proceeds of C$51.75 million… -
SPACS
FG Acquisition Corp. completes acquisition of Strong/MDI Screen Systems Inc. and launches Saltire Capital Ltd.
Goodmans LLP acted for FG Acquisition Corp. ("FGAC"), a special purpose acquisition company, in connection with its acquisition of Strong/MDI Screen Systems, Inc., a leading manufacturer and…